why choose us

300×250 Ad Slot

Research Article: Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England

Date Published: 2023-09-15

Introduction:
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death globally, affecting –% of adults aged and above, and is a leading cause of hospitalizations worldwide. The burden of COPD is expected to grow in the coming years due to factors such as increased global exposure to tobacco and noxious particles, aging populations, and lack of awareness and access to diagnosis. – In the United Kingdom (UK) alone, COPD is the second most common lung disease after asthma, with an estimated . million…

Read more

300×250 Ad Slot